22808-29-3

Basic information

• Product Name: 4-TERT-BUTYL-3,6-DICHLOROPYRIDAZINE
• Synonyms: 4-TERT-BUTYL-3,6-DICHLOROPYRIDAZINE;3,6-Dichloro-4-(1,1-dimethylethyl)pyridazine;3,6-Dichloro-4-tert-butylpyridazine;Pyridazine, 3,6-dichloro-4-(1,1-dimethylethyl)-;Pyridazine, 4-tert-butyl-3,6-dichloro-
• CAS NO: 22808-29-3
• Molecular Formula: C₈H₁₀Cl₂N₂
• Molecular Weight: 205.0844
• Product Categories: Aromatics Compounds;Aromatics;Heterocycles
• Mol File: 22808-29-3.mol
• Article Data: 10

Chemical Properties

• Melting Point: 37-40 °C
• Boiling Point: 297.3°Cat760mmHg
• Flash Point: 161.7°C
• Appearance: /
• Density: 1.231
• Vapor Pressure: 0.00241mmHg at 25°C
• Refractive Index: 1.52
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• Solubility: Chloroform, Dichloromethane
• PKA: -0.40±0.10(Predicted)
• CAS DataBase Reference: 4-TERT-BUTYL-3,6-DICHLOROPYRIDAZINE(CAS DataBase Reference)
• NIST Chemistry Reference: 4-TERT-BUTYL-3,6-DICHLOROPYRIDAZINE(22808-29-3)
• EPA Substance Registry System: 4-TERT-BUTYL-3,6-DICHLOROPYRIDAZINE(22808-29-3)

Safety Data

• Hazardous Substances Data: 22808-29-3(Hazardous Substances Data)

Usage

Chemical Properties

Colourless Oil

InChI:InChI=1/C8H10Cl2N2/c1-8(2,3)5-4-6(9)11-12-7(5)10/h4H,1-3H3

Upstream product

• 141-30-0 3,6-dichlorpyridazine 
• 7664-93-9 sulfuric acid 
• 75-98-9 Trimethylacetic acid 

Downstream Products

• 108287-79-2 3,6-dichloro-4-(2-chloro-1,1-dimethylethyl)pyridazine 
• 108287-83-8 3,6-dichloro-4-<2-chloro-1-(chloromethyl)-1-methylethyl>pyridazine 
• 117144-74-8 3,6-dichloro-4-(2,2-dichloro-1,1-dimethylethyl)pyridazine 
• 108287-87-2 3,6-dichloro-4-<2-chloro-1,1-bis(chloromethyl)ethyl>pyridazine 
• 108287-85-0 3,6-dichloro-4-<2,2-dichloro-1-(chloromethyl)-1-methylethyl>pyridazine 
• 252977-54-1 6-chloro-7-(1,1-dimethyleth-1-yl)-3-(2-fluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazine 
• 102999-49-5 3-amino-6-chloro-5-(1,1-dimethylethyl)pyridazine 
• 107228-69-3 N'-[4-[[6-Chloro-5-(1,1-dimethylethyl)-3-pyridazinyl]oxy]phenyl]-N,N-dimethylurea 
• 252977-55-2 3-chloro-4-(1,1-dimethyleth-1-yl)-6-hydrazinopyridazine 
• 252977-51-8 TPA023 

Relevant articles and documents

Substituted pyridazinone compound and application thereof

The invention provides a substituted pyridazinone compound and application thereof. The substituted pyridazinone compound is a compound shown in a general formula I, or a pharmaceutically acceptable salt, a prodrug, a hydrate or a solvent compound, a poly

OXADIAZOLYLTHIOPHENE DERIVATIVES USEFUL AS HISTONE DEACETYLASE INHIBITORS

A compound of Formula I : (I) or a pharmaceutically acceptable salt thereof, wherein: each R' is QR1; each Q is independently selected from a bond, -C1-C10 alkylene, -C2-C10 alkenylene, -C(O)-, -C(O)O-, -C(O)N(R1)-, -C(O)N(R1)SO2- -N(R1)C(O)-, - N(R1)-, -N(SO2(R1)), -N(R1)SO2- -C(O)NR4R5-, -N(R4R5)C(O)-, -N(R4R5)- - S-, -SO-, -SO2-, -S(O)O-, -SO2N(R1)- and -O-; each R1 is independently selected from H, C1-C10 alkyl, C2-C10 alkenyl, C2-C10 alkynyl, C1-C10 haloalkyl, C1-C10 heteroalkyl, aryl, heteroaryl, C3-C10 cycloalkyl, -(C1-C10 alkylene)-C3-C10 cycloalkyl, halogen, cyano, C1-C10 alkylene- aryl, C1-C10 alkylene heteroaryl, C1-C10 heterocycloalkyl and -(C1-C10 alkylene)- C1-C10 heterocycloalkyl. The compounds are inhibitors of HDAC and therefore have potential utility in the therapy of a number of conditions including cancer and inflammation.

Heterocyclic Compounds Useful as RAF Kinase Inhibitors

The present invention provides compounds useful as inhibitors of Raf protein kinase. The present invention also provides compositions thereof, and methods of treating Raf-mediated diseases.